The First Broad Examination of Michael Reactions in the Presence of a Diverse Array of Acidic Spectator Functional Groups: Enantioselective Synthesis

在多种酸性观众官能团存在下对迈克尔反应的首次广泛检验:对映选择性合成

基本信息

项目摘要

During synthetic route planning acidic functional groups are purposely circumvented by using protection/deprotection protocols; but these protocols do more to increase waste and lower overall yield than any other general ailment of synthesis. Here we suggest that this general problem can be reduced by showing that many common acidic functional groups (pKa= 0 to 14) can be spectators that require no protection during enantioselective Michael reactions. Our preliminary results go beyond high stereochemical achievement, for example several of the demonstrated reactions do not have racemic equivalents, e.g. when a carboxylic acid spectator group is present. Because of the advantages afforded by removing the need for acid based protecting groups, we are now able to suggest the shortest enantioselective syntheses known to date for Pristiq, a Pfizer drug for depression, and an important natural product, Mevalonic acid. From a global perspective, we hope that this research will inspire a push within the synthetic community to broaden synthetic route planning to include more unprotected acidic moieties to allow for more step-efficient synthesis. Here we show that this is possible.
在合成路线规划期间,通过使用保护/去保护方案有意规避酸性官能团;但这些方案比任何其他一般的合成问题更会增加浪费并降低总产率。在这里,我们建议通过证明许多常见的酸性官能团(pKa = 0至14)可以在对映选择性迈克尔反应过程中不需要保护来减少这个普遍问题。我们的初步结果超出了高立体化学成就,例如几个演示的反应没有外消旋等价物,例如当存在羧酸观众基团时。由于消除了对酸基保护基团的需求所带来的优势,我们现在能够建议迄今为止已知的最短的对映选择性合成 Pristiq(一种辉瑞治疗抑郁症的药物)和一种重要的天然产物甲羟戊酸。从全球角度来看,我们希望这项研究能够激发合成界内的推动力,扩大合成路线规划,包括更多未受保护的酸性部分,以实现更高效的合成。在这里我们证明这是可能的。

项目成果

期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Professor Dr. Thomas Nugent其他文献

Professor Dr. Thomas Nugent的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Professor Dr. Thomas Nugent', 18)}}的其他基金

Enantioselective Conversion of Achiral Diketones and Triketones for Shortened Bioactive Molecule Synthesis
非手性二酮和三酮的对映选择性转化以缩短生物活性分子的合成
  • 批准号:
    245372425
  • 财政年份:
    2013
  • 资助金额:
    --
  • 项目类别:
    Research Grants
Enantioselective Ammonium Enolate Based Michael-Henry and Michael-Henry-Aldol Cascade Reactions: Development, Mechanistic Insight, and Applications for Morphine Family Analgesics
基于迈克尔-亨利和迈克尔-亨利-羟醛级联反应的对映选择性烯醇铵:吗啡系列镇痛药的开发、机理洞察和应用
  • 批准号:
    509064606
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
    Research Grants

相似海外基金

Replacing valproate with a safer, broad-spectrum drug for epilepsy treatment
用更安全的广谱药物替代丙戊酸治疗癫痫
  • 批准号:
    MR/Y019334/1
  • 财政年份:
    2024
  • 资助金额:
    --
  • 项目类别:
    Research Grant
MRI: Track 1 Acquisition of a Broad Beam Ion Mill for Advancing Research and Training
MRI:轨道 1 采购宽束离子磨机以推进研究和培训
  • 批准号:
    2320552
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Designing broad-range plant virus resistance using a function-conserving precise genome editing scheme
使用功能保留的精确基因组编辑方案设计广泛的植物病毒抗性
  • 批准号:
    23KK0111
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
'Horticulture' CRISPR Cas-mediated and inter-species transfer of broad-spectrum, potentially durable disease resistance in crop plants (CRIMIST-DR).
“园艺”作物中 CRISPR Cas 介导的广谱、潜在持久抗病性的种间转移 (CRIMIST-DR)。
  • 批准号:
    BB/X011798/1
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Research Grant
Novel Broad-Spectrum Point-of-Care Coagulometer
新型广谱护理点凝血计
  • 批准号:
    10707617
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Discovery of early immunologic biomarkers for risk of PTLDS through machine learning-assisted broad temporal profiling of humoral immune response
通过机器学习辅助的体液免疫反应的广泛时间分析发现 PTLDS 风险的早期免疫生物标志物
  • 批准号:
    10738144
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development of broad-spectrum antiviral compounds derived from foods
开发源自食品的广谱抗病毒化合物
  • 批准号:
    23K10941
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of microclimate for conservation under climate change: evaluating the importance of local-scale factors in comparison with broad-scale factors
气候变化下小气候对保护的作用:评估局部尺度因素与大尺度因素的重要性
  • 批准号:
    22KJ0048
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Broad spectrum inhibitors of paramyxovirus envelope proteins
副粘病毒包膜蛋白的广谱抑制剂
  • 批准号:
    10634368
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Broad Genomic Profiling in patients with advanced lung cancer: empirically assessing adoption, clinical utility, and the value of additional evidence in an evolving landscape of cancer care
晚期肺癌患者的广泛基因组分析:实证评估采用、临床效用以及在不断发展的癌症治疗领域中额外证据的价值
  • 批准号:
    10800129
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了